Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204 Meeting Abstract
| Authors: | Tawbi, H. A. H.; Forsyth, P. A. J.; Algazi, A. P.; Hamid, O.; Hodi, F. S.; Moschos, S. J.; Khushalani, N. I.; Gonzalez, R.; Lao, C. D.; Postow, M. A.; Atkins, M. B.; Ernstoff, M. S.; Puzanov, I.; Kudchadkar, R. R.; Thomas, R. P.; Tarhini, A. A.; Jiang, J.; Avila, A.; Demelo, S.; Margolin, K. A. |
| Abstract Title: | Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204 |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 477s |
| Language: | English |
| ACCESSION: | WOS:000411932203150 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.9507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9507 -- Source: Wos |
